Oxalate retinopathy: an experimental model of a flecked retina

R. Caine, Daniel Albert, M. Lahav, J. Bullock

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The clinical picture resembling fundus albipunctatus was seen to develop in rabbits following subcutaneous injection with dibutyl oxalate. On histologic examination, the flecks were found to be due to intracellular accumulation of calcium oxalate in the RPE cells. The clinical and histologic features of this animal model closely resemble the recently described entity of oxalate retinopathy in humans which was seen in the presence of high circulating oxalate levels. It is suggested that the presence of metabolic disorders or toxicity which are known to cause oxalate depositions should be sought in patients with fundus albipunctatus.

Original languageEnglish (US)
Pages (from-to)359-363
Number of pages5
JournalInvestigative ophthalmology
Volume14
Issue number5
StatePublished - Dec 1 1975
Externally publishedYes

Fingerprint

Oxalates
Retina
Theoretical Models
Calcium Oxalate
Subcutaneous Injections
Animal Models
Rabbits
Fundus Albipunctatus

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Oxalate retinopathy : an experimental model of a flecked retina. / Caine, R.; Albert, Daniel; Lahav, M.; Bullock, J.

In: Investigative ophthalmology, Vol. 14, No. 5, 01.12.1975, p. 359-363.

Research output: Contribution to journalArticle

Caine, R, Albert, D, Lahav, M & Bullock, J 1975, 'Oxalate retinopathy: an experimental model of a flecked retina', Investigative ophthalmology, vol. 14, no. 5, pp. 359-363.
Caine, R. ; Albert, Daniel ; Lahav, M. ; Bullock, J. / Oxalate retinopathy : an experimental model of a flecked retina. In: Investigative ophthalmology. 1975 ; Vol. 14, No. 5. pp. 359-363.
@article{a6ab48caa4a8497abbf1a0a65f38fa57,
title = "Oxalate retinopathy: an experimental model of a flecked retina",
abstract = "The clinical picture resembling fundus albipunctatus was seen to develop in rabbits following subcutaneous injection with dibutyl oxalate. On histologic examination, the flecks were found to be due to intracellular accumulation of calcium oxalate in the RPE cells. The clinical and histologic features of this animal model closely resemble the recently described entity of oxalate retinopathy in humans which was seen in the presence of high circulating oxalate levels. It is suggested that the presence of metabolic disorders or toxicity which are known to cause oxalate depositions should be sought in patients with fundus albipunctatus.",
author = "R. Caine and Daniel Albert and M. Lahav and J. Bullock",
year = "1975",
month = "12",
day = "1",
language = "English (US)",
volume = "14",
pages = "359--363",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "5",

}

TY - JOUR

T1 - Oxalate retinopathy

T2 - an experimental model of a flecked retina

AU - Caine, R.

AU - Albert, Daniel

AU - Lahav, M.

AU - Bullock, J.

PY - 1975/12/1

Y1 - 1975/12/1

N2 - The clinical picture resembling fundus albipunctatus was seen to develop in rabbits following subcutaneous injection with dibutyl oxalate. On histologic examination, the flecks were found to be due to intracellular accumulation of calcium oxalate in the RPE cells. The clinical and histologic features of this animal model closely resemble the recently described entity of oxalate retinopathy in humans which was seen in the presence of high circulating oxalate levels. It is suggested that the presence of metabolic disorders or toxicity which are known to cause oxalate depositions should be sought in patients with fundus albipunctatus.

AB - The clinical picture resembling fundus albipunctatus was seen to develop in rabbits following subcutaneous injection with dibutyl oxalate. On histologic examination, the flecks were found to be due to intracellular accumulation of calcium oxalate in the RPE cells. The clinical and histologic features of this animal model closely resemble the recently described entity of oxalate retinopathy in humans which was seen in the presence of high circulating oxalate levels. It is suggested that the presence of metabolic disorders or toxicity which are known to cause oxalate depositions should be sought in patients with fundus albipunctatus.

UR - http://www.scopus.com/inward/record.url?scp=0016767382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016767382&partnerID=8YFLogxK

M3 - Article

C2 - 1126825

AN - SCOPUS:0016767382

VL - 14

SP - 359

EP - 363

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 5

ER -